Back to Journals » Infection and Drug Resistance » Emerging Trends in Multidrug-Resistant Infections
Infection and Drug Resistance
- View all (4828)
- Volume 19, 2026 (270)
- Volume 18, 2025 (601)
- Volume 17, 2024 (563)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Unlocking Drug Resistance Prediction with AI (3)
- Emerging Trends in Multidrug-Resistant Infections (5)
- Personalized Antimicrobial Strategies: A Path to Precision Therapy (2)
- Antimicrobial Stewardship and Infection Control: A Global Perspective (4)
- Advances in Prosthetic Joint Infections: Current Challenges and Future Solutions (2)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
Emerging Trends in Multidrug-Resistant Infections
Multidrug-resistant infections represent a critical global health crisis, posing significant threats to public health, economics, and patient safety. As resistance to antibiotics increases, healthcare providers face a diminishing arsenal of effective treatments, complicating the management of infections and leading to higher morbidity and mortality rates. This situation results in longer hospital stays and increased medical costs, imposing a substantial economic burden on healthcare systems. Vulnerable populations, such as the elderly and immunocompromised individuals, are particularly at risk, underscoring the urgency to confront this challenge.

Molecular Diagnostics, Antimicrobial Resistance Patterns, and Clinical Outcomes in Hospitalized Pneumonia Patients: A Prospective Study from Jordan and a Call for National Guideline Integration
Alsayed AR, Zihlif M, Abuata OM, Permana AD, Zihlif M
Infection and Drug Resistance 2026, 19:585095
Published Date: 26 February 2026

Sociodemographic and Clinical Correlates of Multidrug-Resistant Uropathogens in Hospitalized Children
Muhsen K, Haleem S, Mansour B, Shapira M, Pitashny M, Masarwa M, Omar M, Na’aminh W, Kassem E
Infection and Drug Resistance 2026, 19:588989
Published Date: 8 April 2026

Impact of Drug-Resistant Tuberculosis Prevention and Control Strategies in Southeast China: Evidence from a Longitudinal Study on Disease Epidemic Trends and Predictions Across 15 Years
Wu Y, Li M, Zhu Y, Peng Y, Wang F, Chen X, Zu Z, Chen B, Zhou L, Chen D
Infection and Drug Resistance 2026, 19:597234
Published Date: 17 April 2026

Legionellosis: Global Epidemiology and Current Perspectives on Diagnosis and Treatment
Ma J, Dong T, Li F, He C, Li B, Liu Z
Infection and Drug Resistance 2026, 19:603565
Published Date: 9 April 2026

Correlation Between Xpert MTB/RIF Results and rpoB Mutations within Probe-Targeted Regions in Mycobacterium tuberculosis Isolates from Sichuan Basin
Li K, Li L
Infection and Drug Resistance 2025, 18:5161-5171
Published Date: 29 September 2025
